Pre-order Enquiry
Request Free Sample
Global HPV Testing Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
SKU ID : GIR-13860873 | Publishing Date : 18-Feb-2019 | No. of pages : 118
Request Sample
Request Customization
Check Discounts
The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.
Scope of the Report:
HPV Testing is mainly used in Cervical Cancer Screening. Cervical Cancer Screening is the biggest application. The main suppliers of HPV testing in the market include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD and Seegene, Inc., Qiagen is the biggest supplier, in 2016 Qiagen revenue was about $ 194.13 million and in 2017 Qiagen revenue will be about $ 204.06 million.Global HPV testing market can be divided into two big markets: Europe and North America. North America is the largest HPV testing region, in 2016, North America HPV testing revenue was about $ 248.12 million in 2016, in 2017, USA HPV testing revenue will be about $ 270.49 million.
The worldwide market for HPV Testing is expected to grow at a CAGR of roughly 8.4% over the next five years, will reach 930 million US$ in 2024, from 580 million US$ in 2019, according to a new study.
This report focuses on the HPV Testing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene, Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
HPV Testing
Follow-up HPV Testing
Co-testing
Market Segment by Applications, can be divided into
Cervical Cancer Screening
Vaginal Cancer Screening
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HPV Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of HPV Testing, with price, sales, revenue and global market share of HPV Testing in 2017 and 2018.
Chapter 3, the HPV Testing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HPV Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, HPV Testing market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe HPV Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Scope of the Report:
HPV Testing is mainly used in Cervical Cancer Screening. Cervical Cancer Screening is the biggest application. The main suppliers of HPV testing in the market include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD and Seegene, Inc., Qiagen is the biggest supplier, in 2016 Qiagen revenue was about $ 194.13 million and in 2017 Qiagen revenue will be about $ 204.06 million.Global HPV testing market can be divided into two big markets: Europe and North America. North America is the largest HPV testing region, in 2016, North America HPV testing revenue was about $ 248.12 million in 2016, in 2017, USA HPV testing revenue will be about $ 270.49 million.
The worldwide market for HPV Testing is expected to grow at a CAGR of roughly 8.4% over the next five years, will reach 930 million US$ in 2024, from 580 million US$ in 2019, according to a new study.
This report focuses on the HPV Testing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene, Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
HPV Testing
Follow-up HPV Testing
Co-testing
Market Segment by Applications, can be divided into
Cervical Cancer Screening
Vaginal Cancer Screening
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HPV Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of HPV Testing, with price, sales, revenue and global market share of HPV Testing in 2017 and 2018.
Chapter 3, the HPV Testing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HPV Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, HPV Testing market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe HPV Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
